Brain Trauma Neuroprotection and Neurorestoration Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Electrophoresis. 2012 Dec;33(24):3693-704. doi: 10.1002/elps.201200196.
Proteomics and systems biology have significantly contributed to biomarker discovery in the field of brain injury. This study utilized 2D-DIGE-PMF-MS as a preliminary screen to detect biomarkers in a rat model of penetrating ballistic-like brain injury (PBBI). Brain-specific systems biology analysis of brain tissue identified 386 proteins having a fold change of more than 2, of which 321 proteins were increased and 65 were decreased 24 h after PBBI compared to sham controls. The majority of upregulated proteins were cytoskeletal (10.5%), nucleic acid binding (9.3%), or kinases (8.9%). Most proteins were involved in protein metabolism (22.7%), signal transduction (20.4%), and development (9.6%). Pathway analysis indicated that these proteins were involved in neurite outgrowth and cell differentiation. Semiquantitative Western blotting of 6, 24, 48, and 72 h after PBBI indicated ubiquitin carboxyl-terminal hydrolase isozyme L1 (a proposed traumatic brain injury biomarker in human clinical trials), tyrosine hydroxylase, and syntaxin-6 were found to be consistently elevated in brain tissue and cerebral spinal fluid after PBBI compared to sham controls. Combining proteomics and brain-specific systems biology can define underlying mechanisms of traumatic brain injury and provide valuable information in biomarker discovery that, in turn, may lead to novel therapeutic targets.
蛋白质组学和系统生物学在脑损伤领域的生物标志物发现中发挥了重要作用。本研究利用 2D-DIGE-PMF-MS 作为初步筛选方法,检测穿透性弹道样脑损伤(PBBI)大鼠模型中的生物标志物。对脑组织进行的脑特异性系统生物学分析鉴定出 386 种具有 2 倍以上变化的蛋白质,与假手术对照组相比,PBBI 后 24 小时有 321 种蛋白质增加,65 种蛋白质减少。上调的大多数蛋白质为细胞骨架(10.5%)、核酸结合(9.3%)或激酶(8.9%)。大多数蛋白质参与蛋白质代谢(22.7%)、信号转导(20.4%)和发育(9.6%)。通路分析表明,这些蛋白质参与轴突生长和细胞分化。PBBI 后 6、24、48 和 72 小时的半定量 Western 印迹分析表明,泛素羧基末端水解酶同工酶 L1(一种在人类临床试验中被提议用于创伤性脑损伤的生物标志物)、酪氨酸羟化酶和突触素-6在 PBBI 后的脑组织和脑脊液中持续升高与假手术对照组相比。蛋白质组学和脑特异性系统生物学的结合可以定义创伤性脑损伤的潜在机制,并提供生物标志物发现中的有价值信息,从而可能导致新的治疗靶点。